<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Lab Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ann Lab Med</journal-id>
      <journal-id journal-id-type="publisher-id">ALM</journal-id>
      <journal-title-group>
        <journal-title>Annals of Laboratory Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2234-3806</issn>
      <issn pub-type="epub">2234-3814</issn>
      <publisher>
        <publisher-name>The Korean Society for Laboratory Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26206695</article-id>
      <article-id pub-id-type="pmc">4510511</article-id>
      <article-id pub-id-type="doi">10.3343/alm.2015.35.5.544</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
          <subj-group subj-group-type="heading">
            <subject>Diagnostic Hematology</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Immature Teratoma and Subsequent Acute Promyelocytic Leukemia in a Pediatric Patient With XYY Syndrome</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Park</surname>
            <given-names>Ju-Heon</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="author-notes" rid="FN1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Choi</surname>
            <given-names>Hyun-Woo</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="author-notes" rid="FN1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Seo</surname>
            <given-names>Bo-Young</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kang</surname>
            <given-names>Min-Goo</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Soo-Hyun</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Baek</surname>
            <given-names>Hee-Jo</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A2">2</xref>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kook</surname>
            <given-names>Hoon</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A2">2</xref>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Shin</surname>
            <given-names>Myung-Geun</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A3">3</xref>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Laboratory Medicine, Chonnam National University Hwasun Hospital, Hwasun-gun, Jeollanam-do, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Pediatrics, Chonnam National University Hwasun Hospital, Hwasun-gun, Jeollanam-do, Korea.</aff>
      <aff id="A3"><label>3</label>Environmental Health Center for Childhood Leukemia and Cancer, Chonnam National University Hwasun Hospital, Hwasun-gun, Jeollanam-do, Korea.</aff>
      <aff id="A4"><label>4</label>Brain Korea 21 Plus Project, Chonnam National University Medical School, Gwangju, Korea.</aff>
      <author-notes>
        <corresp>Corresponding author: Myung-Geun Shin. Department of Laboratory Medicine, Chonnam National University Medical School and Chonnam National University Hwasun Hospital, 160 Ilsimri, Hwasun-eup, Hwasun-gun, Jeollanam-do 519-890, Korea. Tel: +82-61-379-7950, Fax: +82-61-379-7984, <email>mgshin@chonnam.ac.kr</email></corresp>
        <fn id="FN1" fn-type="equal">
          <p><sup>*</sup>These two authors equally contributed to this work.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>15</day>
        <month>7</month>
        <year>2015</year>
      </pub-date>
      <volume>35</volume>
      <issue>5</issue>
      <fpage>544</fpage>
      <lpage>547</lpage>
      <history>
        <date date-type="received">
          <day>07</day>
          <month>1</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>18</day>
          <month>3</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>12</day>
          <month>6</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Korean Society for Laboratory Medicine.</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <funding-group>
        <award-group>
          <funding-source country="KR">National Research Foundation of Korea</funding-source>
          <award-id>2011-0015304</award-id>
          <award-id>2011-0030034</award-id>
        </award-group>
        <award-group>
          <funding-source country="KR">Ministry of Health and Welfare</funding-source>
          <award-id>2013-1320070</award-id>
        </award-group>
      </funding-group>
    </article-meta>
  </front>
  <body>
    <p>XYY syndrome is a rare sex chromosome abnormality that occurs in 1 of 1,000 male births, and shows a normal phenotype with the exception of increased stature [<xref rid="B1" ref-type="bibr">1</xref>]. However, other clinical characteristics such as psychological dysfunction [<xref rid="B2" ref-type="bibr">2</xref>] and urinary tract and hepatobiliary system abnormalities have been reported with XYY syndrome [<xref rid="B3" ref-type="bibr">3</xref>]. Here, we describe the first case of XYY syndrome with the occurrence of a cervical immature teratoma and subsequent acute promyelocytic leukemia (APL).</p>
    <p>The patient was born as a full-term baby and had an irregular-shaped mass measuring 10 cm, on the left side of his neck. Magnetic resonance imaging showed a well-defined, enhanced mass, measuring 5.6&#xD7;4.9&#xD7;4.5 cm in size (<xref ref-type="fig" rid="F1">Fig. 1A</xref>). Alpha-fetoprotein (AFP) in the blood was markedly above the normal ranges (30,066.0 IU/mL). Conventional cytogenetics of peripheral blood revealed a 47,XYY karyotype, indicating an extra Y chromosome. Pathological diagnosis of the excised mass confirmed an immature teratoma, grade 3 (<xref ref-type="fig" rid="F1">Fig. 1B and C</xref>). The patient was treated with three cycles of cisplatin (10 mg/m<sup>2</sup> for 5 days) and etoposide (50 mg/m<sup>2</sup> for 5 days) after surgical resection. The serum AFP level after the first cycle of chemotherapy was 289.3 IU/mL, and the level was normalized after four months of age.</p>
    <p>Twenty-eight months after completion of chemotherapy, the patient showed multiple bruises on his extremities and bicytopenia (white blood cells: 6.3&#xD7;10<sup>9</sup>/L, hemoglobin: 8.4 g/dL, and platelets: 18&#xD7;10<sup>9</sup>/L). Bone marrow (BM) aspiration showed that 43% of the promyelocytes were abnormal (<xref ref-type="fig" rid="F1">Fig. 1D and E</xref>). Flow cytometric analysis of BM cells revealed a clonal myeloid cell population that was positive for CD13 (60.4%), CD33 (58.7%), and MPO (96.4%), and negative for CD34 (4.1%) and HLA-DR (1.9%).</p>
    <p>Conventional cytogenetics of BM cells revealed a 47,XYY karyotype without abnormalities in chromosomes 15 and 17 (<xref ref-type="fig" rid="F2">Fig. 2A</xref>). However, a <italic>PML/RARA</italic> rearrangement was detected by FISH (<xref ref-type="fig" rid="F2">Fig. 2B</xref>), multiplex reverse-transcription PCR (RT-PCR) (HemaVision kit; DNA-Diagnostic, Risskov, Denmark), and quantitative real-time PCR (qRT-PCR). We confirmed <italic>PML/RARA</italic> rearrangement by direct sequencing (<xref ref-type="fig" rid="F2">Fig. 2C</xref>).</p>
    <p>The patient was treated with ATRA, and after the first induction chemotherapy, morphological remission was achieved with a decrease in <italic>PML-RARA/ABL</italic>, as determined by qRT-PCR. After two cycles of consolidation chemotherapy, the patient began maintenance chemotherapy.</p>
    <p>According to recent reports, the incidence of cancer in the XYY syndrome population is not significantly different from that in the general population; however, mortality from cancer is significantly higher [<xref rid="B1" ref-type="bibr">1</xref><xref rid="B4" ref-type="bibr">4</xref>].</p>
    <p>Hematologic malignancies are the most commonly reported neoplasms associated with XYY syndrome, and other neoplasms are reported rarely [<xref rid="B5" ref-type="bibr">5</xref>]. In this case, APL occurred 28 months after chemotherapy for the teratoma. Therapy-related AML occurs with a latency period of one to five years after treatment with topoisomerase II inhibitors and other chemotherapeutics. It is often associated with balanced chromosomal translocations, and characteristics and outcomes are not very different from those of <italic>de novo</italic> AML [<xref rid="B9" ref-type="bibr">9</xref>]. Etoposide-related AML occurs mostly in patients treated with a high cumulative dose (&gt;2,000 mg/m<sup>2</sup>) [<xref rid="B7" ref-type="bibr">7</xref>]. In this patient, because of etoposide use, the 28-month interval, and the <italic>PML-RARA</italic> rearrangement, therapy-related APL was suspected. However, the cumulative dose of etoposide was much lower than 2,000 mg/m<sup>2</sup>. Therefore, we also considered other possibilities such as malignant transformation of the teratoma to leukemia [<xref rid="B8" ref-type="bibr">8</xref>] or the genetic vulnerability of hematopoietic tissue itself to chemotherapy in XYY syndrome cases. Leukemia associated with a teratoma is reported to occur simultaneously or within a short interval of about six months (range, 1-22 months) [<xref rid="B9" ref-type="bibr">9</xref>]. It is presumed that hematopoietic microfoci within the primary teratoma tissue might be the origin of the leukemia; this hypothesis is supported by identical clonal aberrations in both teratoma and leukemia [<xref rid="B9" ref-type="bibr">9</xref>]. A more likely explanation for pathogenesis is an association with the effects of XYY syndrome itself. First, dysfunction or malformation of the kidneys and liver are common abnormalities in patients with XYY syndrome, making them more susceptible to cytotoxic complications of chemotherapy [<xref rid="B10" ref-type="bibr">10</xref>]. Second, constitutional aberrations might result in a high susceptibility to potentially leukemia-inducing agents. Considering these possibilities, careful administration of chemotherapy dose and attentive follow-up examinations are recommended when treating neonates with XYY syndrome.</p>
    <p>In summary, although further evaluations in large-scale epidemiological studies will be required to demonstrate the association between XYY syndrome, teratoma, and subsequent leukemia, our case showed a new phenotype, the presentation of teratoma and APL, in the spectrum of disease in pediatric XYY syndrome.</p>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>This study was supported by grants from the National Research Foundation of Korea (NRF) (No. 2011-0015304), and the Leading Foreign Research Institute Recruitment Program (No. 2011-0030034) through the NRF funded by the Ministry of Education, Science and Technology (MEST), and a grant from the National R&amp;D Program for Cancer Control, Ministry of Health &amp; Welfare, Republic of Korea (No. 2013-1320070). We thank Seung Yeob Lee who provided advice during the drafting of the manuscript, and Sung-Du Jeong and Jae-Sung Lee who provided technical support for molecular genetic studies.</p>
    </ack>
    <fn-group>
      <fn fn-type="conflict">
        <p><bold>Authors' Disclosures of Potential Conflicts of Interest:</bold> No potential conflicts of interest relevant to this article were reported.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stochholm</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Juul</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gravholt</surname>
              <given-names>CH</given-names>
            </name>
          </person-group>
          <article-title>Diagnosis and mortality in 47,XYY persons: a registry study</article-title>
          <source>Orphanet J Rare Dis</source>
          <year>2010</year>
          <volume>5</volume>
          <fpage>15</fpage>
          <pub-id pub-id-type="pmid">20509956</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jacobs</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Brunton</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Melville</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Brittain</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>McClemont</surname>
              <given-names>WF</given-names>
            </name>
          </person-group>
          <article-title>Aggressive behavior, mental sub-normality and the XYY male</article-title>
          <source>Nature</source>
          <year>1965</year>
          <volume>208</volume>
          <fpage>1351</fpage>
          <lpage>1352</lpage>
          <pub-id pub-id-type="pmid">5870205</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>C&#xF4;t&#xE9;</surname>
              <given-names>GB</given-names>
            </name>
            <name>
              <surname>Tsomi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Papadakou-Lagoyanni</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Petmezaki</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Oligohydramnios syndrome and XYY karyotype</article-title>
          <source>Ann Genet</source>
          <year>1978</year>
          <volume>21</volume>
          <fpage>226</fpage>
          <lpage>228</lpage>
          <pub-id pub-id-type="pmid">314260</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Higgins</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Swerdlow</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Schoemaker</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Wright</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Jacobs</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
          <collab>UK Clinical Cytogenetics Group</collab>
          <article-title>Mortality and cancer incidence in males with Y polysomy in Britain: a cohort study</article-title>
          <source>Hum Genet</source>
          <year>2007</year>
          <volume>121</volume>
          <fpage>691</fpage>
          <lpage>696</lpage>
          <pub-id pub-id-type="pmid">17457613</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Limacher</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Girard-Lemaire</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Jeandidier</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Chenard-Neu</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Kassem</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Flori</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Gastrointestinal stromal tumor in an XYY/XY male</article-title>
          <source>Cancer Genet Cytogenet</source>
          <year>2002</year>
          <volume>133</volume>
          <fpage>152</fpage>
          <lpage>155</lpage>
          <pub-id pub-id-type="pmid">11943343</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="book">
          <person-group person-group-type="editor">
            <name>
              <surname>Swerdlow</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Campo</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <source>WHO Classification of tumours of haematopoietic and lymphoid tissues</source>
          <edition>4th ed</edition>
          <publisher-loc>Lyon</publisher-loc>
          <publisher-name>International Agency for Research on Cancer</publisher-name>
          <year>2008</year>
          <fpage>127</fpage>
          <lpage>129</lpage>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schneider</surname>
              <given-names>DT</given-names>
            </name>
            <name>
              <surname>Hilgenfeld</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Schwabe</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Behnisch</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Zoubek</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wessalowski</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Acute myelogenous leukemia after treatment for malignant germ cell tumors in children</article-title>
          <source>J Clin Oncol</source>
          <year>1999</year>
          <volume>17</volume>
          <fpage>3226</fpage>
          <lpage>3233</lpage>
          <pub-id pub-id-type="pmid">10506623</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harms</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Zahn</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>G&#xF6;bel</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Schneider</surname>
              <given-names>DT</given-names>
            </name>
          </person-group>
          <article-title>Pathology and molecular biology of teratomas in childhood and adolescence</article-title>
          <source>Klin Padiatr</source>
          <year>2006</year>
          <volume>218</volume>
          <fpage>296</fpage>
          <lpage>302</lpage>
          <pub-id pub-id-type="pmid">17080330</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nichols</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Heerema</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Griep</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Tricot</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Hematologic neoplasia associated with primary mediastinal germ-cell tumors</article-title>
          <source>N Engl J Med</source>
          <year>1990</year>
          <volume>322</volume>
          <fpage>1425</fpage>
          <lpage>1429</lpage>
          <pub-id pub-id-type="pmid">2158625</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shibata</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kami</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kishi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hamaki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ueyama</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Miyakoshi</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Severe regimen-related toxicity occurring in a patient with XYY syndrome receiving allogeneic peripheral blood stem cell transplantation</article-title>
          <source>Ann Hematol</source>
          <year>2002</year>
          <volume>81</volume>
          <fpage>407</fpage>
          <lpage>409</lpage>
          <pub-id pub-id-type="pmid">12185516</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Fig. 1</label>
      <caption>
        <title>Radiographical and morphological findings of teratoma and bone marrow study. (A) A coronal magnetic resonance image (MRI) at birth showed a unilateral, large, well-defined, and enhanced mass. (B) A well-circumscribed and irregular-shaped mass was extirpated from left side of the neck (7 cm&#xD7;5 cm). (C) The tissue biopsy showed an immature teratoma with primitive neuroepithelial rosettes lined by basophilic cells (hematoxylin and eosin stain, &#xD7;100). (D) Bone marrow findings at diagnosis showed depleted trilineage cellular component, proliferation of abnormal promyelocytes with large purple granules and irregular-shaped (kidney-shaped or bilobed) nuclei (Wright-Giemsa stain, &#xD7;400). (E) High magnification images from (D) disclosed abnormal promyelocytes (Wright-Giemsa stain, &#xD7;1,000).</title>
      </caption>
      <graphic xlink:href="alm-35-544-g001"/>
    </fig>
    <fig id="F2" orientation="portrait" position="float">
      <label>Fig. 2</label>
      <caption>
        <title>Cytogenetic and molecular studies at diagnosis of acute promyelocytic leukemia. (A) Giemsa-banded karyotype of bone marrow showing 47,XYY chromosomal arrangement. Additional Y (in arrow) and intact chromosomes 15 and 17 are observed. (B) Dual-color FISH with <italic>PML-RARA</italic> probes demonstrates the presence of <italic>PML-RARA</italic> fusion (in arrows). (C) Direct sequencing for the confirmation of <italic>PML-RARA</italic> rearrangement shows that the 396-bp band of M4D contains a fusion transcript of <italic>PML</italic> exon 4-<italic>RARA</italic> exon 3 and that the 353-bp band of M8C contains a fusion transcript of <italic>PML</italic> exon 6-RARA exon 3. The fusion transcript of <italic>PML</italic> exon 4-<italic>RARA</italic> exon 3 is a result of alternative splicing of the <italic>PML</italic> exon 6-<italic>RARA</italic> exon 3 fusion gene.</title>
      </caption>
      <graphic xlink:href="alm-35-544-g002"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
